best mid cap stocks q1 2017

Aurinia Pharmaceuticals (AUPH) had the highest return in Q1 2017 by a mid-cap US stock, returning 243%.

ASSETQUARTER% RETURN
Aurinia Pharmaceuticals (AUPH)
Q1 2017
242.99%
Pulse Biosciences (PLSE)
Q1 2017
214%
Talos Energy (TALO)
Q1 2017
186.78%
TG Therapeutics (TGTX)
Q1 2017
142.71%
Applied Opt (AAOI)
Q1 2017
136.82%
Star Bulk Carriers (SBLK)
Q1 2017
126.71%
Viridian Therapeutics (VRDN)
Q1 2017
126.28%
Aehr Test Systems (AEHR)
Q1 2017
105.56%
Palvella Therapeutics (PVLA)
Q1 2017
88.41%
Nektar Therapeutics (NKTR)
Q1 2017
88.06%
Ichor (ICHR)
Q1 2017
79.95%
Chemours (CC)
Q1 2017
78.48%
Ultra Clean (UCTT)
Q1 2017
73.92%
Spyre Therapeutics (SYRE)
Q1 2017
70.87%
Mesoblast (MESO)
Q1 2017
67.85%
National Beverage (FIZZ)
Q1 2017
65.45%
Option Care Health (OPCH)
Q1 2017
55.96%
Celsius (CELH)
Q1 2017
54.76%
MakeMyTrip (MMYT)
Q1 2017
54.46%
Taseko Mines (TGB)
Q1 2017
53.49%
Transportadora de Gas del Sur SA ADR (TGS)
Q1 2017
52.9%
RH (RH)
Q1 2017
50.19%
TAL Education (TAL)
Q1 2017
50.1%
Wix (WIX)
Q1 2017
50.06%
Universal Display (OLED)
Q1 2017
50.05%
Mid-cap stocks are treated as having a market cap between $2B and $10B.